Alkeon Capital Management - NEOLEUKIN THERAPEUTICS INC ownership

NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 87 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.33 and the average weighting 0.0%.

Quarter-by-quarter ownership
Alkeon Capital Management ownership history of NEOLEUKIN THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$1,084,000
-70.0%
224,945
-55.0%
0.00%
-66.7%
Q3 2021$3,615,000
-21.7%
500,0000.0%0.01%
-14.3%
Q2 2021$4,615,000
-25.0%
500,0000.0%0.01%
-22.2%
Q1 2021$6,155,000
-12.7%
500,0000.0%0.01%
-18.2%
Q4 2020$7,050,000
+193.8%
500,000
+150.0%
0.01%
+175.0%
Q3 2020$2,400,000
-27.7%
200,0000.0%0.00%
-50.0%
Q2 2020$3,320,000
+45.9%
200,0000.0%0.01%
-20.0%
Q1 2020$2,276,000
-7.6%
200,0000.0%0.01%
+11.1%
Q4 2019$2,464,000200,0000.01%
Other shareholders

There were no reported owners of NEOLEUKIN THERAPEUTICS INC in Q3 2021.

NameSharesValueWeighting ↓
View complete list of NEOLEUKIN THERAPEUTICS INC shareholders